Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin US4579852082
Ticker IART
Company INTEGRA LIFE SCIENCES HOLDINGS
Currency $
Price
Aware Investor Index (AII) 0.0003
Recommendation STRONG SELL
P/E 107.98
ROE 3.76 %
Capitalization 3,911,742,240 $
Dividend Yield 0.00 %
P/S 3.29
AII Position 700
P/E Position 701
ROE Position 667
Capitalization Position 582
Dividend Yield Position 596
Sales 1,188,236,000 $
10-Year Average Earnings 36,226,900 $
Shares Outstanding 79,121,000
Equity 962,306,000 $
Dividend per Share 0 $
Industry Medical Equipment
Country United States
INTEGRA LIFE SCIENCES HOLDINGS Investor Relations Web Site http://investor.integralife.com/







Sales:

YEAR MONTH AMOUNT
2017 12 1,188,236,000.00 $
2016 12 992,075,000.00 $
2015 12 882,734,000.00 $
2014 12 796,717,000.00 $
2013 12 696,832,000.00 $

Earnings:

YEAR MONTH AMOUNT
2017 12 64,743,000.00 $
2016 12 74,564,000.00 $
2015 12 -3,519,000.00 $
2014 12 34,004,000.00 $
2013 12 -21,067,000.00 $
2012 12 41,204,000.00 $
2011 12 27,989,000.00 $
2010 12 65,669,000.00 $
2009 12 50,955,000.00 $
2008 12 27,727,000.00 $

Equity:

YEAR MONTH AMOUNT
2017 12 962,306,000.00 $
2016 12 839,667,000.00 $
2015 12 751,443,000.00 $
2014 12 704,322,000.00 $
2013 12 670,180,000.00 $
2012 12 517,775,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2017 12 79,121,000
2016 12 79,194,000
2015 12 35,677,000
2014 12 32,960,000
2013 12 28,416,000
2012 12 28,516,000

 












Bloomberg News for INTEGRA LIFE SCIENCES HOLDINGS:



Google News for INTEGRA LIFE SCIENCES HOLDINGS:

Simply Wall St - 20 hours ago
Should Integra LifeSciences Holdings Corporation (NASDAQ:IART ...
To keep the lesson grounded in practicality, we'll use ROE to better understand Integra LifeSciences Holdings Corporation (NASDAQ:IART).
Nasdaq
Integra LifeSciences Holdings Corporation (IART)
Integra LifeSciences Holdings Corporation (IART) ... The following slide deck was published by Integra LifeSciences Holdings Corporation in ...
Talk Traders (press release) (blog)
Integra LifeSciences Launches Integra® Titan™ Reverse Shoulder ...
PLAINSBORO, N.J., Jan. 10, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global ...
Fairfield Current
Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director
PLAINSBORO, N.J., Jan. 09, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global ...
Seeking Alpha - 5 days ago
Equity Review: Investors Keen on Integra LifeSciences Holdings ...
Major market players are buzzing over Integra LifeSciences Holdings Corporation (NASDAQ:IART) as their share price hit $45.51 at the end of ...
GlobeNewswire (press release) - 5 days ago
Integra LifeSciences Holdings Corporation (NASDAQ:IART) Is on a ...
Over the past 12 weeks, shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) have seen a move of -28.1%. Looking back over ...
GlobeNewswire (press release) - 6 days ago
Integra LifeSciences in-licenses new should system
Integra LifeSciences Holdings (NASDAQ:IART) inks a license and development agreement with Consortium of Focused Orthopedists, LLC for a ...
MONReport
Integra Lifesciences launches Integra Titan Reverse Shoulder ...
Integra LifeSciences (NASDAQ:IART) announces the full market release of ... Now read: Hill-Rom Holdings (HRC) Presents At 37th Annual J.P. ...
NMSU Nеws
Stock Survey: Following the Target Price for Integra LifeSciences ...
Investors tracking shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART) may be closely following analyst price target estimates.
GuruFocus.com
Quant Investors Are Taking a Thorough Look at Integra LifeSciences ...
The ERP5 of Integra LifeSciences Holdings Corporation (IART) is 2452. The lower the ERP5 rank, the more undervalued a company is thought ...


Back